Dockside LLC bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 6,582 shares of the financial services provider's stock, valued at approximately $1,221,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in MRSH. Brighton Jones LLC raised its position in shares of Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock worth $1,856,000 after acquiring an additional 2,960 shares during the period. Bison Wealth LLC raised its position in shares of Marsh & McLennan Companies by 39.6% in the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider's stock worth $651,000 after acquiring an additional 869 shares during the period. Glenview Trust co raised its position in shares of Marsh & McLennan Companies by 10.8% in the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider's stock worth $852,000 after acquiring an additional 379 shares during the period. Osterweis Capital Management Inc. raised its position in shares of Marsh & McLennan Companies by 18,440.0% in the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider's stock worth $203,000 after acquiring an additional 922 shares during the period. Finally, Diversify Advisory Services LLC acquired a new position in shares of Marsh & McLennan Companies in the second quarter worth about $1,307,000. 87.99% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of the company's stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer owned 116,811 shares of the company's stock, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company's stock.
Analysts Set New Price Targets
MRSH has been the subject of a number of analyst reports. Barclays decreased their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating for the company in a research report on Wednesday, April 8th. Morgan Stanley decreased their price objective on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an "equal weight" rating for the company in a research report on Monday, April 6th. Bank of America decreased their price objective on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an "underperform" rating for the company in a research report on Tuesday, April 14th. Mizuho cut their target price on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a "neutral" rating for the company in a research note on Monday, April 13th. Finally, Citigroup raised shares of Marsh & McLennan Companies from a "neutral" rating to a "buy" rating and set a $200.00 target price for the company in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $200.19.
Read Our Latest Report on MRSH
Marsh & McLennan Companies Price Performance
MRSH stock opened at $168.67 on Monday. The stock has a market cap of $81.49 billion, a PE ratio of 21.08, a P/E/G ratio of 2.46 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $220.32.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts' consensus estimates of $3.21 by $0.08. The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. Marsh & McLennan Companies's quarterly revenue was up 7.6% compared to the same quarter last year. On average, analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.